Regularization and grouping -omics data by GCA method: A transcriptomic case | JoVE Visualize

Area of Science:

Bioinformatics
Computational Biology
Genomics

Background:

-Omics datasets, particularly transcriptomic data, are complex and require robust analytical methods for pattern discovery.
Analyzing gene expression profiles in diseases like Multiple Myeloma is crucial for understanding disease mechanisms and patient stratification.
Existing methods may not efficiently handle the high dimensionality and inherent noise in large -omics datasets.

Purpose of the Study:

To introduce and evaluate Grade Correspondence Analysis (GCA) and Grade Correspondence Cluster Analysis (GCCA) for ordering and grouping -omics data.
To demonstrate the utility of GCA and GCCA in identifying regularities and characteristic gene expression profiles within a Multiple Myeloma patient cohort.
To provide a framework for analyzing and visualizing complex gene expression patterns.

Main Methods:

Application of Grade Correspondence Analysis (GCA) for iterative permutation of data matrix rows and columns to maximize rank correlation coefficients (tau-Kendall, rho-Spearman).
Utilizing Grade Correspondence Cluster Analysis (GCCA) for grouping and clustering the rank-ordered data.
Regularization of transcriptomic data to enable clustering of genes (columns) and patients (rows), followed by aggregation for visualization.

Main Results:

GCA successfully identified regularities in the transcriptomic data of 256 Multiple Myeloma patients.
The methods enabled the creation of distinct gene expression profiles for different patient groups.
Clustering of genes and patients facilitated a more interpretable representation of the complex dataset.
Visualization of aggregated patient profiles provided insights into disease-specific gene expression patterns.

Conclusions:

GCA and GCCA offer a powerful and alternative approach for the analysis and interpretation of -omics datasets.
These methods facilitate the differentiation and characterization of gene expression profiles associated with specific patient groups.
The approach aids in identifying relevant genes and biochemical processes underlying diseases like Multiple Myeloma.